Literature DB >> 9009310

Identification of D motif epitopes in Staphylococcus aureus fibronectin-binding protein for the production of antibody inhibitors of fibronectin binding.

Q Sun1, G M Smith, C Zahradka, M J McGavin.   

Abstract

A fibronectin-binding protein (FnBP) adhesin of Staphylococcus aureus possesses three 37- or 38-amino-acid motifs (D1, D2, and D3) that can each bind fibronectin (Fn) with low affinity and that in tandem comprise D1-3, a high-affinity Fn-binding domain. To identify epitopes for the generation of adhesion-blocking antibodies, rabbits were immunized with recombinant D1-3 or with a glutathione S-transferase fusion protein, GSTD1-3. Affinity-purified antibodies from the D1-3 immunization were poor inhibitors of Fn binding to S. aureus and recognized several different epitopes, with a preference for clusters of acidic amino acids that do not contribute to Fn binding. Antibodies generated with GSTD1-3 as an immunogen were more effective inhibitors, but concentrations in excess of 20 microg x ml-1 did not promote more than 50% inhibition. These antibodies were highly specific for amino acids 21 to 34 of D1 (D1(21-34)), which contain a sequence that is essential for Fn binding and are identical to D2 at 12 of 14 residues. Neither antibody preparation recognized D3(20-33) of the D3 motif, where the only homology to D1(21-34) and D2(21-34) comprises a sequence motif, GG(X3,4)(I/V)DF, that is critical to Fn binding. However, antibodies specific for both D1(21-34) and D3(20-33) could be obtained by using synthetic peptides corresponding to these sequences as immunogens. F(ab')2 fragments derived from these antibodies each caused 40 to 50% inhibition of Fn binding to S. aureus, and their ability to bind to purified FnBP was eliminated by competing Fn. However, mixtures of the two F(ab')2 preparations did not provide additive or synergistic inhibition of Fn binding. Therefore, inhibition of Fn binding to S. aureus requires antibodies specific for D1(21-34) and D3(20-33), but a mixture of antibodies specific for both sequences did not provide complete inhibition.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9009310      PMCID: PMC176093          DOI: 10.1128/iai.65.2.537-543.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides.

Authors:  C Signäs; G Raucci; K Jönsson; P E Lindgren; G M Anantharamaiah; M Höök; M Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  Fibronectin binding determinants of the Staphylococcus aureus fibronectin receptor.

Authors:  M J McGavin; G Raucci; S Gurusiddappa; M Höök
Journal:  J Biol Chem       Date:  1991-05-05       Impact factor: 5.157

3.  Host factors selectively increase staphylococcal adherence on inserted catheters: a role for fibronectin and fibrinogen or fibrin.

Authors:  P Vaudaux; D Pittet; A Haeberli; E Huggler; U E Nydegger; D P Lew; F A Waldvogel
Journal:  J Infect Dis       Date:  1989-11       Impact factor: 5.226

4.  Isolation and characterization of a fibronectin receptor from Staphylococcus aureus.

Authors:  G Fröman; L M Switalski; P Speziale; M Höök
Journal:  J Biol Chem       Date:  1987-05-15       Impact factor: 5.157

Review 5.  Staphylococcus aureus. The persistent pathogen (second of two parts).

Authors:  J N Sheagren
Journal:  N Engl J Med       Date:  1984-05-31       Impact factor: 91.245

6.  Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus.

Authors:  J M Kuypers; R A Proctor
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

Review 7.  Staphylococcal vaccines: a realistic dream.

Authors:  A I Fattom; R Naso
Journal:  Ann Med       Date:  1996-02       Impact factor: 4.709

8.  The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.

Authors:  E D Shapiro; A T Berg; R Austrian; D Schroeder; V Parcells; A Margolis; R K Adair; J D Clemens
Journal:  N Engl J Med       Date:  1991-11-21       Impact factor: 91.245

9.  A novel method of activation of cross-linked agaroses with 1,1'-carbonyldiimidazole which gives a matrix for affinity chromatography devoid of additional charged groups.

Authors:  G S Bethell; J S Ayers; W S Hancock; M T Hearn
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

10.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

View more
  11 in total

1.  Synthetic peptide immunogens elicit polyclonal and monoclonal antibodies specific for linear epitopes in the D motifs of Staphylococcus aureus fibronectin-binding protein, which are composed of amino acids that are essential for fibronectin binding.

Authors:  M Huesca; Q Sun; R Peralta; G M Shivji; D N Sauder; M J McGavin
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

Review 2.  New approaches towards the identification of antibiotic and vaccine targets in Streptococcus pneumoniae.

Authors:  Anne Marie Di Guilmi; Andréa Dessen
Journal:  EMBO Rep       Date:  2002-08       Impact factor: 8.807

3.  Staphylococcus caprae strains carry determinants known to be involved in pathogenicity: a gene encoding an autolysin-binding fibronectin and the ica operon involved in biofilm formation.

Authors:  J Allignet; S Aubert; K G Dyke; N El Solh
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

4.  Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease.

Authors:  M J McGavin; C Zahradka; K Rice; J E Scott
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  The fibronectin-binding protein Fnm contributes to adherence to extracellular matrix components and virulence of Enterococcus faecium.

Authors:  Sudha R Somarajan; Sabina Leanti La Rosa; Kavindra V Singh; Jung H Roh; Magnus Höök; Barbara E Murray
Journal:  Infect Immun       Date:  2015-09-14       Impact factor: 3.441

6.  Identification and characterization of a novel fibronectin-binding protein on the surface of group A streptococci.

Authors:  C L Rocha; V A Fischetti
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

7.  Extracellular adherence protein from Staphylococcus aureus enhances internalization into eukaryotic cells.

Authors:  Axana Haggar; Muzaffar Hussain; Helena Lönnies; Mathias Herrmann; Anna Norrby-Teglund; Jan-Ingmar Flock
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

8.  Description of staphylococcus serine protease (ssp) operon in Staphylococcus aureus and nonpolar inactivation of sspA-encoded serine protease.

Authors:  K Rice; R Peralta; D Bast; J de Azavedo; M J McGavin
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

9.  Variance in fibronectin binding and fnb locus polymorphisms in Staphylococcus aureus: identification of antigenic variation in a fibronectin binding protein adhesin of the epidemic CMRSA-1 strain of methicillin-resistant S. aureus.

Authors:  K Rice; M Huesca; D Vaz; M J McGavin
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

10.  Two Dimensional Structural Analysis and Expression of a New Staphylococcus aureus Adhesin Based Fusion Protein.

Authors:  Jamshid Faghri; Delavar Shahbazzadeh; Kamran Pooshang Bagheri; Sharareh Moghim; Hajieh Ghasemian Safaei; Bahram Nasr Esfahani; Hossein Fazeli; Rahmatolah Yazdani; Hamid Mirmohammad Sadeghi
Journal:  Iran J Basic Med Sci       Date:  2012-03       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.